South Korea Says ‘AI Is No Longer a Choice’ as Agrifoodtech Funding Jumps 171%

Why It Matters

The initiative accelerates AI integration in a land‑scarce, aging farming sector, positioning Korea as a technology exporter and attracting capital. It also ties agricultural innovation to broader biotech ambitions, reshaping the country’s economic landscape.

Key Takeaways

• AI becomes core foundation for Korean agriculture by 2026
• Funding surged 171% to $253 M in 2025
• 82% of deals are seed or early‑stage, median $4.1 M
• GINT’s Series C raised $9.8 M for autonomous farm tech
• Government aims top biotech economy by 2030, merging bio committees

Pulse Analysis

South Korea’s AX strategy reflects a global shift toward data‑driven farming, but the country’s unique constraints amplify its urgency. With only 22% of land arable, Korean policymakers see AI as the lever to squeeze productivity from limited fields while mitigating climate volatility and an aging rural workforce. By establishing shared AI‑enabled equipment centers and smart processing hubs, the government hopes to democratize high‑tech tools for farms that previously could not afford them, fostering a more resilient food system.

Capital is already following policy signals. AgFunder’s 2026 report shows agrifoodtech funding leapt to $253 million in 2025, a 171% jump from the prior year, even as deal volume fell. Early‑stage ventures dominate, with 82% of 49 deals at seed or Series A levels and a median ticket of $4.1 million. AI‑powered robotics firms like GINT, which secured a $9.8 million Series C, illustrate how autonomous tractors and crop‑management software are becoming mainstream. The breadth of AI applications—from logistics platforms such as Vroong to AI‑driven slaughterhouse management like ROBOS—signals a holistic digital overhaul across the supply chain.

The agricultural push dovetails with Korea’s broader biotech aspirations. Merging the National Bio Committee with the Biohealth Innovation Committee and launching a hub with Samsung Biologics and Eli Lilly aim to cement the nation among the world’s top biotech economies by 2030. This convergence of agri‑AI and biotech could generate cross‑sector synergies, such as microbiome‑enhanced seeds and AI‑optimized fermentation processes. However, sustaining momentum will require follow‑on financing for early‑stage firms and clear pathways to commercial scale, ensuring the AI foundation translates into tangible productivity gains and exportable technologies.